In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

The Employees' Provident Fund Organisation (EPFO) has extended the deadline for Universal Account Number (UAN) activation and Aadhaar seeding of bank accounts under the Employment Linked Incentive ...

To QB or not to QB? That was the question Eli Stowers asked himself as the 2023 college football season approached for New Mexico State. The question answered itself. The answer not to QB.

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

The Employees Provident Fund Organisation (EPFO) has extended the deadline for UAN activation and seeding of bank accounts to Aadhaar to avail the benefits under the ELI (Employment Linked ...

Eli Puretz wants others to avoid the mistake he made. Puretz, a 29-year old real estate investor, is facing a sentence of five years in prison for his role in a multi-million-dollar commercial ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...

The Employee Provident Fund Organisation (EPFO) has extended the deadline to January 15, 2024, for UAN activation and seeding of your bank account with Aadhaar for availing of the benefits under the ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate ...

Eli Lilly LLY1.80%increase; green up pointing triangle is surging ahead in the race to dominate the lucrative obesity market. That is the takeaway from the disappointing Novo Nordisk NOVO.B 1.69 ...

The Food and Drug Administration approved Eli Lilly's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder. The weekly injection is now ...

In a study, people who took Zepbound had fewer breathing interruptions. The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...